Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $6.23-$16.44 |
Market Cap | $1.8B |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $52M |
Revenue Growth (YoY) | 0.8% |
Gross Profit (12 Mos) | -$175M |
Diluted EPS | -$1.44 |
News
See moreYahoo Finance • 11 days ago
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Yahoo Finance • 15 days ago
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
Yahoo Finance • last month
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
About
CEO | Dr. Pravin U. Dugel M.D. |
CFO | Mr. Donald Notman Jr. |
Address | 15 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 325 |